Two targets, thromboxane A2 receptor (TBXA2R) and plateletactivating factor receptor (PTAFR) were found to be novel AP target receptorspotentially associated with pneumonia. This evidence concerns the gene TBXA2R and susceptibility to pneumonia measurement.